Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-05-27

Biosafe coronavirus vaccine vector for the prevention of human infections of the enteric and respiratory tract (BIOSAFE-VACCINE-VECTOR)

Objetivo

The objective is a comprehensive approach for the treatment and protection against human enteric and respiratory infectious diseases by using a vector based on recently isolated corona virus coda genome that amplifies the gene of interest inducing protection without the production of infectious virus and the development of a transgenic mouse model to test vector efficacy. The vector is produced in packaging cell line that provides an essential component for virus vector replication, missing in the virus genome. Additional bio safety strategies, like the relocation of the genome-packaging signal, will lead to an extremely secure virus vector. The expression system will be applied to the protection against human enteric rotavirus and corona virus causing enteric necrosis in children or respiratory infections in adult.

Ámbito científico (EuroSciVoc)

Programa(s)

Tema(s)

Convocatoria de propuestas

Datos no disponibles

Régimen de financiación

CSC - Cost-sharing contracts

Coordinador

CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
Aportación de la UE
Sin datos
Dirección
Campus de la Universidad Autonoma de Madrid
28049 MADRID
España
Coste total
Sin datos

Participantes (5)